Compare · MDLN vs NUVA
MDLN vs NUVA
Side-by-side comparison of Medline Inc. (MDLN) and NuVasive Inc. (NUVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and NUVA operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 18.7x NUVA ($2.57B).
- MDLN has hit the wire 7 times in the past 4 weeks while NUVA has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 18 for NUVA).
- Company
- Medline Inc.
- NuVasive Inc.
- Price
- $35.95-1.74%
- $39.75-2.21%
- Market cap
- $48.08B
- $2.57B
- 1M return
- +11.97%
- -
- 1Y return
- -11.77%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2004
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 18
NuVasive Inc.
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest NUVA
- SEC Form 15-12G filed by NuVasive Inc.
- SEC Form SC 13G/A filed by NuVasive Inc. (Amendment)
- SEC Form EFFECT filed by NuVasive Inc.
- SEC Form EFFECT filed by NuVasive Inc.
- SEC Form EFFECT filed by NuVasive Inc.
- SEC Form EFFECT filed by NuVasive Inc.
- SEC Form EFFECT filed by NuVasive Inc.
- SEC Form EFFECT filed by NuVasive Inc.
- SEC Form 4 filed by Wolterman Dan
- SEC Form 4 filed by Raimundo Amy Belt